Publications by authors named "James Geraghty"

Claim this Profile
A
A Qualitative Study to Understand the Barriers and Facilitators in Smoking Cessation Practices Among Oncology Health Care Practitioners in One Health System.
Kate Frazer, Nancy Bhardwaj, Patricia Fox, Ailsa Lyons, Shiraz Syed, James Geraghty

Nicotine Tob Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in Ireland.
Lynda M McSorley, Mehala Tharmabala, Fathiya Al Rahbi, Fergus Keane, Denis Evoy, James G Geraghty

Curr Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nodal positivity in patients with clinically and radiologically node-negative breast cancer treated with neoadjuvant chemotherapy: multicentre collaborative study.
Alexandra M Zaborowski, Katie Doogan, Siobhan Clifford, Gavin Dowling, Farah Kazi, James Geraghty

Br J Surg· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The accuracy of MRI in detecting pathological complete response following neoadjuvant chemotherapy in different breast cancer subtypes.
Miroslava Kuzmova, Carolyn Cullinane, Claire Rutherford, Damian McCartan, Jane Rothwell, James Geraghty

Surg Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review of oncological outcomes after nipple-sparing mastectomy for breast cancer.
Alexandra M Zaborowski, Simon Roe, Jane Rothwell, Denis Evoy, James Geraghty

J Surg Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Treatment Score post-5 years as a predictor of late distant recurrence in hormone receptor-positive breast cancer: systematic review and meta-analysis.
Amber Shrestha, Carolyn Cullinane, Denis Evoy, James Geraghty, Jane Rothwell

Br J Surg· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fertility treatment and breast-cancer incidence: meta-analysis.
Carolyn Cullinane, Hannah Gillan, James Geraghty, Denis Evoy, Jane Rothwell

BJS Open· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Postoperative Wound Complications on Oncological Outcomes Following Immediate Breast Reconstruction for Breast Cancer: A Meta-analysis.
Ishwarya Balasubramanian, Tim Harding, Michael R Boland, Eanna J Ryan, James Geraghty

Clin Breast Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal timing of surgery following breast cancer neoadjuvant chemotherapy: A systematic review and meta-analysis.
Carolyn Cullinane, Amber Shrestha, Ahmed Al Maksoud, Jane Rothwell, Denis Evoy, James Geraghty

Eur J Surg Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibromatosis of the breast: a 10-year multi-institutional experience and review of the literature.
Michael R Boland, Timothy Nugent, Jack Nolan, Johnny O'Mahony, Sylvia O'Keeffe, James Geraghty

Breast Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review and meta-analysis of the utility of lymphoscintigraphy in the management of clinically node-negative breast cancer.
Michael R Boland, Helen M Heneghan, Éanna J Ryan, Qurat Ain, Stephen J Skehan, James Geraghty

Breast J· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
False-negative rate of ultrasound-guided fine-needle aspiration cytology for identifying axillary lymph node metastasis in breast cancer patients.
Gavin Kane, Christina Fleming, Helen Heneghan, Damian McCartan, Philip James, James Geraghty

Breast J· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change of paradigm in treating elderly with breast cancer: are we undertreating elderly patients?
Chwanrow Karim Baban, Liam Devane, James Geraghty

Ir J Med Sci· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast screening in symptomatic women over 35 years of age: improvements in service efficiency.
Roisin M O'Cearbhaill, Sandra Hembrecht, Liam A Devane, Jane Rothwell, Denis Evoy, James Geraghty

Ir J Med Sci· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of timing of trastuzumab initiation on long-term outcome of patients with early-stage HER2-positive breast cancer: the "one thousand HER2 patients" project.
Giuseppe Gullo, Naomi Walsh, David Fennelly, Reetesh Bose, Janice Walshe, James Geraghty

Br J Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
US immigration order strikes against biotech.
Jeremy M Levin, Steven H Holtzman, John Maraganore, Paul J Hastings, Ron Cohen, James A Geraghty

Nat Biotechnol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second international consensus guidelines for breast cancer in young women (BCY2).
Shani Paluch-Shimon, Olivia Pagani, Ann H Partridge, Eran Bar-Meir, Lesley Fallowfield, James Geraghty

Breast· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of novel germline mutations for breast cancer in non-BRCA1/2 families.
Fatima Aloraifi, Trudi McDevitt, Rui Martiniano, Jonah McGreevy, Russell McLaughlin, James G Geraghty

FEBS J· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delineating transcriptional networks of prognostic gene signatures refines treatment recommendations for lymph node-negative breast cancer patients.
Fiona Lanigan, Gerard L Brien, Yue Fan, Stephen F Madden, Emilia Jerman, James Geraghty

FEBS J· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein-truncating variants in moderate-risk breast cancer susceptibility genes: a meta-analysis of high-risk case-control screening studies.
Fatima Aloraifi, Damian McCartan, Trudi McDevitt, Andrew J Green, Adrian Bracken, James Geraghty

Cancer Genet· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Value of Isosulfan Blue Dye in Addition to Isotope Scanning in the Identification of the Sentinel Lymph Node in Breast Cancer Patients With a Positive Lymphoscintigraphy: A Randomized Controlled Trial (ISRCTN98849733).
Elma Anna OʼReilly, Ruth S Prichard, Dhafir Al Azawi, Nitin Aucharaz, Gabrielle Kelly, James Geraghty

Ann Surg· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancer.
Fatima Aloraifi, Michael R Boland, Andrew J Green, James G Geraghty

Surg Oncol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fine needle aspiration cytology in symptomatic breast lesions: still an important diagnostic modality?
Myles J Smith, Cynthia C Heffron, Jane R Rothwell, Barbara M Loftus, Michael Jeffers, James G Geraghty

Breast J· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pure primary osteosarcoma of the breast.
Emmeline Nugent, Lai Mun Wang, Orla McCormack, Michael Jeffers, Jane Rothwell, James Geraghty

Breast J· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding the biopharmaceutical industry's involvement in fighting neglected diseases.
James A Geraghty

Health Aff (Millwood)· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis